Literature DB >> 33886145

Rationalizing the Unprecedented Stereochemistry of an Enzymatic Nitrile Synthesis through a Combined Computational and Experimental Approach.

Hilmi Yavuzer1, Yasuhisa Asano2, Harald Gröger1.   

Abstract

In this contribution, the unique and unprecedented stereochemical phenomenon of an n class="Chemical">aldoxime dehydratase-catalyzed enantioselective dehydration of racemic E- and Z-aldoximes with selective formation of both enantiomeric forms of a chiral nitrile is rationalized by means of molecular modelling, comprising in silico mutations and docking studies. This theoretical investigation gave detailed insight into why with the same enzyme the use of racemic E- and Z-aldoximes leads to opposite forms of the chiral nitrile. The calculated mutants with a larger or smaller cavity in the active site were then prepared and used in biotransformations, showing the theoretically predicted decrease and increase of the enantioselectivities in these nitrile syntheses. This validated model also enabled the rational design of mutants with a smaller cavity, which gave superior enantioselectivities compared to the known wild-type enzyme, with excellent E-values of up to E>200 when the mutant OxdRE-Leu145Phe was utilized.
© 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Entities:  

Keywords:  aldoxime dehydratase; chiral nitriles; enantioselectivity; enzyme models; rational protein design

Year:  2021        PMID: 33886145     DOI: 10.1002/anie.202017234

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  1 in total

1.  Chemoenzymatic one-pot reaction from carboxylic acid to nitrile via oxime.

Authors:  Melissa Horvat; Victoria Weilch; Robert Rädisch; Sebastian Hecko; Astrid Schiefer; Florian Rudroff; Birgit Wilding; Norbert Klempier; Miroslav Pátek; Ludmila Martínková; Margit Winkler
Journal:  Catal Sci Technol       Date:  2021-11-30       Impact factor: 6.119

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.